Despite remarkable advancements over the last few decades, managing coronary artery disease (CAD) in patients is still very difficult, as seen by the substantial residual risk of ischemic events. Research on coronary stents has traditionally been the primary emphasis of interventional cardiology; however, with the introduction of second-generation angioplasty stents, current developments have mostly focused on target vessel revascularization (TVR) along with advanced technologies.
Globally, the rate of coronary artery disease is on the rise. This can be ascribed to changes in lifestyle, aging populations, and more knowledge and exposure to medical therapies. This necessitates certain technical advancements in this field that might lead to better outcomes. This blog will explore how technologies like AI and robotics change the global percutaneous coronary intervention (PCI) patterns and strengthen the global medical sector.
Using AI in Angioplasty
The angioplasty landscape is being revolutionized by artificial intelligence (AI), improving patient outcomes, treatment planning, and diagnostic accuracy. Artificial intelligence (AI) algorithms can identify coronary artery disease (CAD) and the best intervention course more quickly and accurately by analyzing large datasets such as clinical studies, patient information, and medical pictures. Predictive patient risk variables using machine learning models help create customized treatment plans and improve procedures’ success rate.
AI also helps with real-time decision assistance during angioplasty operations, which allows cardiologists to position stents optimally and navigate complicated anatomy. This technology decreases the chance of problems, speeds up procedures, and improves the effectiveness of medical teams.
AI-driven advancements also assist long-term management plans, anticipate possible issues, and monitor patient recovery, all of which are important aspects of post-procedural care. Artificial Intelligence is revolutionizing worldwide cardiovascular care by improving and simplifying angioplasty procedures. This allows for better precision, efficiency, and customization of care to meet the needs of each patient.
Optical Coherence Tomography System (OCT) – A Breakthrough
In 2023, the Symbiosis Speciality Hospital in Mumbai integrated Ultreon® technology with the newest optical coherence tomography (OCT) device, Optis Mobile Next.
OCT is an advanced imaging method that uses infrared light to create high-resolution pictures of the body’s coronary arteries. It gives cardiologists precise information on the size of the stent and balloon, the post-deployment evaluation, and the morphology of the plaque. This results in full stent expansion and, ultimately, superior long-term outcomes. By automatically recognizing different characteristics, integrating AI with the most recent Ultreon® software improves the interpretation of OCT images and empowers cardiologists to arrive at accurate conclusions.
Optical coherence tomography (OCT) will transform India thanks to the integration of Ultreon® technology with the newest OCT equipment, Optis Mobile Next. This cutting-edge imaging technique raises the bar for heart disease diagnosis and treatment with its remarkable picture quality, accurate measurements, and automatic parameter identification. As OCT is added to difficult angioplasty instances, cardiologists can accurately conduct intricate operations like Rotablation and Left Main Bifurcation.
The latest OCT equipment, Optis Mobile Next, will revolutionize optical coherence tomography (OCT) in India by incorporating Ultreon® technology. With its outstanding image quality, precise measurements, and automated parameter identification, this state-of-the-art imaging method sets a new standard for diagnosing and treating cardiac disease. Cardiologists can accurately perform complex procedures like Rotablation and Left Main Bifurcation when OCT is added to challenging angioplasty cases.
This is not intended to replace the function or knowledge of interventional cardiologists; rather, it is meant to assist them in the cath lab by validating their instincts and providing the crucial data that their hands and eyes require to improve PCI operations.
Robotics to Play a Key Role
During PCI, an R-PCI system allows control of intracoronary devices, including balloons and stents, as well as coronary guidewires from a secure control cockpit. The first iteration of an R-PCI system, the CorPath 200 (Corindus Vascular Robotics), was employed in the preliminary feasibility testing. This technology has been substantially enhanced, with the CorPath GRX (Corindus Vascular Robotics) being the most recent version.
For instance, Robocath, a company that creates, develops, and markets cutting-edge robotic platforms for managing vascular illnesses, recently announced the accomplishment of the very first coronary angioplasty in China, which was made possible by using its R-OneTM automated platform.
This robotic-assisted operation is the first intervention in clinical research conducted by CathBot, a collaboration between Robocath and MedBot, MicroPort Scientific Corporation’s robot-focused subsidiary. Over 100 patients from four sites will participate in this groundbreaking clinical investigation. The aim is to get the National Medical Products Administration (NMPA) to approve the R-One robotic infrastructure for marketing in China.
Conclusion
With continued innovations primed to bring about major improvements in cardiovascular treatment, the future potential of robotics and artificial intelligence in angioplasty appears bright. The capacity of AI to examine large datasets will keep advancing the precision of diagnoses and the customization of treatment regimens, improving patient outcomes. Robotics will offer and ease up more complex, less invasive treatments that enhance accuracy and shorten recuperation periods.
Increased robotics and AI integration might result in fully or mostly autonomous systems, improving procedure efficiency and increasing access to specialist treatment. With the development of these technologies, more advanced telemedicine applications that provide remote expert assistance are possible. In the future, robots and artificial intelligence will work together harmoniously to transform angioplasty and influence the course of cardiovascular therapies.